A New York-based company’s claim that it should have won one of the state’s five initial medical marijuana licenses has taken a big step forward.
An appellate panel in Albany County Supreme Court agrees with Hudson Health Extracts that the scoring methodology used by state regulators to assess part of the company’s 2015 marijuana application was “arbitrary and capricious.”
In a recent eight-page decision, the judges have sent the matter back to the state health department for a “substantive view of the financial standing portion of the application” and determine whether to grant Hudson an MMJ license.
If Hudson Health wins a license, that could open the door to other unsuccessful applicants during that time, industry experts have said.
Business leaders need reliable industry data and in-depth analysis to make smart investments and informed decisions in these uncertain economic times.
Order your 2022 MJBiz Factbook, out now!
Featured Inside:
- 200+ pages and 50 charts with key data points
- State-by-state guide to regulations, taxes & opportunities
- Segmented research reports for the marijuana + hemp industries
- Accurate financial forecasts + investment trends
Stay ahead of the curve and avoid costly missteps in the rapidly evolving cannabis industry.
It also comes at a time that New York is preparing to launch a lucrative multibillion-dollar recreational marijuana industry.
Although litigation such as Hudson’s is common in marijuana licensing, the case stood out because the company scored 43rd in the financial standing portion despite having more than $18 million in capital, real estate secured for a facility and experience producing medical marijuana in two other states.
Jeff Smith can be reached at jeff.smith@mjbizdaily.com.
